icon-folder.gif   Conference Reports for NATAP  
 
 

AASLD

The Liver Meeting
Washington DC
October 2017
Back grey_arrow_rt.gif
 
 
 
In Vivo Study of a LNP siRNA Investigational Agent Applied Sequentially with Immunomodulatory Treatments for Chronic Hepatitis B Infection
 
 
  Reported by Jules Levin
AASLD: The Liver Meeting®
2017, October 20-24, 2017, Washington, DC
 
Emily P. Thi1, Hui Huang1, Luying Pei1, Xin Ye1, Chris Pasetka1, Angela Miller1, Alice H.L. Li1, Agnes Jarosz1, Sara Majeski1, Jang-June Park1, Chris Moore1, Rene Rijnbrand1, Amy C.H. Lee1, Michael J. Sofia1 1 Arbutus Biopharma Corp, Burnaby, BC, Canada & Warminster, PA, United States

1110171

1110172

1110173

1110174

1110175

1110176

1110177